Benchmark Evidence Led by Latin America: Trial of Intracranial Pressure - Pediatrics

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-12
SponsorUniversity of Washington

About this trial

Narrative:

Worldwide, traumatic brain injury (TBI) is a leading cause of death and disability among children and adolescents. The Investigators aim to test whether pediatric TBI treatment guided by invasive intracranial pressure monitoring produces better patient outcomes than care guided by a protocol without invasive monitoring. Study findings will inform clinical practice in treating pediatric severe TBI globally. Focused didactic and experience-based learning opportunities will increase the research capacity of pediatric intensivists in Latin America.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Provision of signed and dated informed consent form by the parent(s) or guardian(s)

Non-penetrating TBI

Admission to study hospital within 24 hours of injury

Total GCS score ≤ 8 on admission or within first 48 hours after injury (measured using pediatric GCS 1 for children < 2 years old and standard GCS for older children)

Disqualifiers

Motor GCS score of 6

GCS of 3 with bilaterally fixed and dilated pupils

Injury thought to be intentionally inflicted by a family member or caregiver.

Trial design

Design model

Parallel

Treatments tested in this trial

  • ICP

    Other intervention

    The intervention is a management protocol that includes ICP monitoring for children with severe traumatic brain injury

  • CREVICE

    Other intervention

    The intervention is a management protocol that is based on imaging and clinical examinations without ICP monitoring for children with severe traumatic brain injury

Treatment groups

428 Participants
are divided into 2 treatment groups
Group A: ICP monitoring based ProtocolActive comparator 1 intervention
Group B: No ICP Monitoring Protocol CREVICEActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Pediatric Quality of Life Inventory (PedsQL)

PedsQL is a generic, health-related quality of life instrument developed to measure the core dimensions of physical, cognitive, mental, social health, and role (school) function. Minimum and maximum values: 0-100. Higher scores have better outcomes.

Time frame
6 months after injury

Secondary outcomes

1

Pediatric Quality of Life Inventory (PedsQL)

PedsQL is a generic, health-related quality of life instrument developed to measure the core dimensions of physical, cognitive, mental, social health, and role (school) function. Minimum and maximum values: 0 - 100. Higher the score means a better outcome.

Time frame
3 months after injury
2

Glasgow Outcome Scale - Extended (GOS-E) Pediatric

GOS-E is the most common measure of functional outcome in adult TBI trials. Its pediatric version is the primary outcome in the NINDS-funded ADAPT study. Minimum and maximum values: 1-8. Higher score has worse outcomes.

Time frame
3 and 6 months after injury
3

Mortality

Percent of participants who have died by the assessment time.

Time frame
3 and 6 months
4

Brain-specific interventions

Total number of individual interventions directed at treating measured or suspected intracranial hypertension (i.e., brain-specific treatment) per hour summed over the duration of brain-specific treatment in ICU. Time Frame for brain-specific treatments is through acute hospitalization, an average of one (1) month and for GOS-E Peds is conducted 3 and 6 months after injury.

Time frame
1 month average

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Washington

Lead sponsor

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborator